EverSource Wealth Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $421K | Buy |
946
+380
| +67% | +$169K | 0.02% | 521 |
|
|
2025
Q1 | $274K | Buy |
566
+161
| +40% | +$78K | 0.02% | 553 |
|
|
2024
Q4 | $163K | Sell |
405
-28
| -6% | -$11.3K | 0.01% | 728 |
|
|
2024
Q3 | $201K | Sell |
433
-165
| -28% | -$76.7K | 0.01% | 553 |
|
|
2024
Q2 | $296K | Buy |
598
+33
| +6% | +$16.4K | 0.02% | 442 |
|
|
2024
Q1 | $222K | Buy |
565
+9
| +2% | +$3.53K | 0.02% | 456 |
|
|
2023
Q4 | $226K | Buy |
556
+2
| +0.4% | +$814 | 0.02% | 403 |
|
|
2023
Q3 | $193K | Buy |
554
+15
| +3% | +$5.21K | 0.02% | 405 |
|
|
2023
Q2 | $190K | Sell |
539
-46
| -8% | -$16.2K | 0.02% | 407 |
|
|
2023
Q1 | $184K | Sell |
585
-4
| -0.7% | -$1.26K | 0.02% | 383 |
|
|
2022
Q4 | $170K | Sell |
589
-7
| -1% | -$2.02K | 0.03% | 375 |
|
|
2022
Q3 | $172K | Buy |
596
+171
| +40% | +$49.3K | 0.04% | 322 |
|
|
2022
Q2 | $120K | Buy |
425
+268
| +171% | +$75.7K | 0.03% | 336 |
|
|
2022
Q1 | $41K | Sell |
157
-5
| -3% | -$1.31K | 0.01% | 503 |
|
|
2021
Q4 | $35K | Buy |
+162
| New | +$35K | 0.01% | 495 |
|